finding support at 50MA (monthly)
pink color (monthly trend line)
blue color (weekly trend line and support levels)
Catalyst:
Cadila Healthcare: Company's biologics manufacturing facility (Zydus Biologics) received an Establishment Inspection Report (EIR) from the USFDA signifying the successful closure of the audit. The plant had completed the USFDA audit during August 14-24, 2018 with zero 483 observations.
tested 23.6% fib levels a couple of times
may fill gap of previous day's gap down
target fib levels
pink color (monthly trend line)
blue color (weekly trend line and support levels)
Catalyst:
Cadila Healthcare: Company's biologics manufacturing facility (Zydus Biologics) received an Establishment Inspection Report (EIR) from the USFDA signifying the successful closure of the audit. The plant had completed the USFDA audit during August 14-24, 2018 with zero 483 observations.
tested 23.6% fib levels a couple of times
may fill gap of previous day's gap down
target fib levels
Comment:
no trade criteria not met
Trade closed manually